Research Diogonistics Inc entered the industry of Diagnostic Substances in 1970 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 325412, which describes it as a Diagnostic Substances. For further clarification, the SIC classifies this business under the code 2835 and described it as a Diagnostic Substances. The business provides service to the B2B market.
To acquire more information, please contact Bret G Wien by calling (973) 584-7019 during business hours. You can also write to the business’ Single Location at 60 Pleasant Hill Road, Flanders, New Jersey NJ 07836. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Research Diogonistics Inc |
| Representative: | Bret G Wien |
| Place of Business: | 60 Pleasant Hill Road, Flanders, NJ 07836 |
| Contact Number: | (973) 584-7019 |
| Type of Service: | Diagnostic Substances |
| SIC Number: | 2835 |
| NAICS Number: | 325412 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 1970 |
| Income/Year: | $100.000 to $499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Research Diogonistics Inc is a company operating from Morris, New Jersey providing professional Diagnostic Substances and relevant B2B variables. It was founded in 1970 and registered with the SIC code 2835 as Diagnostic Substances, and with the NAICS code 325412 as Diagnostic Substances.
With a current employee count of 1 to 4, Research Diogonistics Inc has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Bret G Wien at (973) 584-7019 for related queries, or to locate its Single Location using the coordinates 40.835317,-74.695446.
The Single Location can also be found at the street address 60 Pleasant Hill Road in Flanders, New Jersey 07836 and can be engaged online through the company website at , the company Twitter , and Facebook page .